Methyl p-hydroxybenzoate


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000015 Abnormalities, Multiple PMID:23637088; PMID:29360218
MESH:D001289 Attention Deficit Disorder with Hyperactivity PMID:32283359
MESH:D001724 Birth Weight PMID:25061923; PMID:32283359
MESH:D004065 Digestive System Abnormalities PMID:23637088
MESH:D004487 Edema PMID:23637088
MESH:D005124 Eye Abnormalities PMID:23637088
MESH:D007247 Infertility, Female PMID:27286252
MESH:D011297 Prenatal Exposure Delayed Effects PMID:36470324
MESH:D017449 Dermatitis, Allergic Contact PMID:26795242
MESH:D047928 Premature Birth PMID:32283359
MESH:D049188 Prenatal Injuries PMID:23637088

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.